Pertussis Acellular Vaccine Adjuvanted With TQL1055
Clinical trial NCT04793620 · TERMINATED
Trial details
- NCT number
- NCT04793620
- Sponsor
- Adjuvance Technologies, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2021-08-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.